News & Analysis as of

Joint Venture Commercial Marketing

Goodwin

EMA’s Issues Statement of Non-Compliance for Biocon’s Biosimilar Manufacturing Facility

Goodwin on

As we’ve posted here, Biocon and Mylan are jointly developing a portfolio of biosimilars, and they have filed applications for marketing authorization in the European Union for three biosimilar products: Fulphila...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide